Retrieve available abstracts of 69 articles: HTML format
Single Articles
June 2025
LU Y, Ni J, Huang S, Guo Y, et al Epidemiological characteristics of human parainfluenza virus infections and
phylogenetic analysis of human parainfluenza virus type 3 isolated from children
with respiratory tract infections from 2020 to 2022 in Zhejiang, China.
Arch Virol. 2025;170:157. PubMedAbstract available
JIN H, Cho YR, Jung YT Single-particle quantification of SARS-CoV-2 virus-like particles using flow
virometry.
Arch Virol. 2025;170:149. PubMedAbstract available
May 2025
LIU X ACE2, a therapeutic target of COVID-19, needs to be treated with caution.
Arch Virol. 2025;170:143. PubMedAbstract available
CHEN T, Xu W, Duan P, Jiang S, et al MF59-like adjuvant containing yeast-derived squalene enhances the humoral immune
response to cell-derived influenza vaccine.
Arch Virol. 2025;170:134. PubMedAbstract available
April 2025
SVYATCHENKO SV, Boldyrev ND, Panova AS, Kolosova NP, et al Seroprevalence of anti-influenza antibodies in humans and characterization of
seasonal influenza viruses isolated in Russia during the 2023-2024 flu season.
Arch Virol. 2025;170:118. PubMedAbstract available
HUANG Z, Zhang R, Yao D, Fu H, et al Avian influenza A(H5N6) virus detected during live-poultry market surveillance
linked to a human infection in Changsha, China, from 2020 to 2023.
Arch Virol. 2025;170:96. PubMedAbstract available
March 2025
YE QY, Jiang ZT, Jiang Y, Cai JW, et al Effectiveness of inactivated COVID-19 vaccine against symptom severity in
hospitalized COVID-19 patients infected with the Omicron variant.
Arch Virol. 2025;170:88. PubMedAbstract available
ZHANG H, Ouyang S, Qu Y, Li Z, et al Humoral immune response characteristics of vulnerable populations against
SARS-CoV-2 strains EG.5 and JN.1 after infection with strains BA.5 and XBB.
Arch Virol. 2025;170:82. PubMedAbstract available
January 2025
SAKUMA S, Mine J, Uchida Y, Kumagai A, et al Long-term immune responses induced by low-dose infection with high pathogenicity
avian influenza viruses can protect mallards from reinfection with a heterologous
strain.
Arch Virol. 2025;170:33. PubMedAbstract available
ARVIA R, Rocca A, Casciato B, Stincarelli MA, et al High-resolution melting analysis for detection of nucleotide mutation markers in
the polymerase-acidic (PA) gene of influenza virus that are associated with
baloxavir marboxil resistance.
Arch Virol. 2025;170:29. PubMedAbstract available
ASHRAF MA, Raza MA, Imran A, Amjad MN, et al Next-generation vaccines for influenza B virus: advancements and challenges.
Arch Virol. 2025;170:25. PubMedAbstract available
REHMAN Z, Edington K, Jamal Z, Kritz-Wilson A, et al The introduction of the SARS-CoV-2 BA.4 lineage into Pakistan.
Arch Virol. 2025;170:26. PubMedAbstract available
December 2024
ZALI M, Sadat Larijani M, Bavand A, Moradi L, et al Circulatory microRNAs as potential biomarkers for different aspects of COVID-19.
Arch Virol. 2024;170:8. PubMedAbstract available
NAVARRO-LOPEZ R, Valdez-Gomez HE, Zalapa-Hernandez M, Solis-Hernandez M, et al An epizootic of highly pathogenic avian influenza virus H7N3 in a Mexican
ecological reserve.
Arch Virol. 2024;170:6. PubMedAbstract available
GUNASEKARA E, Hair-Bejo M, Aini I, Omar AR, et al Molecular characterisation of novel reassortants of the G57 genotype of
low-pathogenic avian influenza H9N2 virus isolated from poultry farms in
Malaysia.
Arch Virol. 2024;170:3. PubMedAbstract available
MISHRA S, Pandey A, Verma J, Rajala MS, et al Analysis of the interaction of influenza a virus nucleoprotein with host cell
nucleolin.
Arch Virol. 2024;170:1. PubMedAbstract available
November 2024
ZHANG WX, Zou L, Cui Y, Zhou Y, et al Molecular epidemiology of herpangina in the subcenter of Beijing, China: a
surveillance study during 2021-2022.
Arch Virol. 2024;169:245. PubMedAbstract available
October 2024
WU YJ, Feng WW, Wu ZL, Zhang YY, et al Prim-O-glucosylcimifugin alleviates influenza virus-induced pneumonia in mice by
inhibiting the TGF-beta1/PI3KCD/MSK2/RELA signalling pathway.
Arch Virol. 2024;169:232. PubMedAbstract available
LI F, Zhu Y, Li Q, Guan X, et al Genomic characteristics of human respiratory syncytial virus from children in
China during 2017-2020.
Arch Virol. 2024;169:219. PubMedAbstract available
NIYOMDECHA N, Boonarkart C, Thongon S, Auewarakul P, et al Comparative study of the propagation and plaque titration conditions for human
coronavirus OC43 as a surrogate for SARS-CoV-2.
Arch Virol. 2024;169:214. PubMedAbstract available
September 2024
ICHIKAWA T, Hiono T, Okamatsu M, Maruyama J, et al Hemagglutinin and neuraminidase of a non-pathogenic H7N7 avian influenza virus
coevolved during the acquisition of intranasal pathogenicity in chickens.
Arch Virol. 2024;169:207. PubMedAbstract available
WANG H, Wang J, Zhang J, Song J, et al Graphene oxide nanoparticles inhibit H9N2 influenza A virus infectivity by
destroying viral coat proteins.
Arch Virol. 2024;169:192. PubMedAbstract available
July 2024
FANG F, Wang B, Lu X, Wang L, et al miR-126a-5p inhibits H1N1-induced inflammation and matrix protease secretion in
lung fibroblasts by targeting ADAMTS-4.
Arch Virol. 2024;169:164. PubMedAbstract available
May 2024
HE L, Cao J, Xie X, Zhang Y, et al Effects and mechanism of Qingke Pingchuan granules against influenza virus
infection.
Arch Virol. 2024;169:130. PubMedAbstract available
ASADIPOOYA K, Asadipooya A, Adatorwovor R Combination of spironolactone and DPP-4 inhibitors for treatment of SARS-CoV-2
infection: a literature review.
Arch Virol. 2024;169:122. PubMedAbstract available
April 2024
TARE DS, Keng SS, Walimbe AM, Pawar SD, et al Phylogeography and gene pool analysis of highly pathogenic avian influenza H5N1
viruses reported in India from 2006 to 2021.
Arch Virol. 2024;169:111. PubMedAbstract available
YOUSFI FZE, Haroun AE, Nebhani C, Belayachi J, et al Prevalence of the protective OAS1 rs10774671-G allele against severe COVID-19 in
Moroccans: implications for a North African Neanderthal connection.
Arch Virol. 2024;169:109. PubMedAbstract available
HAIDER SA, Jamal Z, Tahir F, Salman M, et al Genomic characterization of human respiratory syncytial virus circulating in
Islamabad, Pakistan, during an outbreak in 2022-2023.
Arch Virol. 2024;169:106. PubMedAbstract available
BEDAIR NM, Sakr MA, Mourad A, Eissa N, et al Molecular characterization of the whole genome of H9N2 avian influenza virus
isolated from Egyptian poultry farms.
Arch Virol. 2024;169:99. PubMedAbstract available
KUTKAT O, Gomaa M, Aboulhoda BE, Moatasim Y, et al Genetic and virological characteristics of a reassortant avian influenza A H6N1
virus isolated from wild birds at a live-bird market in Egypt.
Arch Virol. 2024;169:95. PubMedAbstract available
TRAN DH, Do HDK, Tran HT, Pham TNM, et al Rapid identification of SARS-CoV-2 strains via isothermal enzymatic recombinase
amplification and nanopore sequencing.
Arch Virol. 2024;169:87. PubMedAbstract available
March 2024
LI X, Ding G, Li S, Liu C, et al Proteomic characteristics of the treatment trajectory of patients with COVID-19.
Arch Virol. 2024;169:84. PubMedAbstract available
YUAN J, Pan J, Zhang X, Gao R, et al TRIM21 reduces H1N1-induced inflammation and apoptosis by regulating the
TBK1-IRF3 signaling pathway in A549 cells.
Arch Virol. 2024;169:74. PubMedAbstract available
February 2024
KIM HJ, Park JG, Moon KS, Jung SB, et al Identification and characterization of a marine bacterium extract from Mameliella
sp. M20D2D8 with antiviral effects against influenza A and B viruses.
Arch Virol. 2024;169:41. PubMedAbstract available
January 2024
ZHUANG J, Yan Z, Zhou T, Li Y, et al The role of receptors in the cross-species spread of coronaviruses infecting
humans and pigs.
Arch Virol. 2024;169:35. PubMedAbstract available
WANG Y, Liu Y, Wang Y, Mai H, et al Clinical characteristics of outpatients with influenza-B-associated pneumonia and
molecular evolution of influenza B virus in Beijing, China, during the 2021-2022
influenza season.
Arch Virol. 2024;169:30. PubMedAbstract available
TANIGUCHI K, Noshi T, Omoto S, Sato A, et al The impact of PA/I38 substitutions and PA polymorphisms on the susceptibility of
zoonotic influenza A viruses to baloxavir.
Arch Virol. 2024;169:29. PubMedAbstract available
LIU H, Wang J, Li S, Sun Y, et al The unfolded protein response pathway as a possible link in the pathogenesis of
COVID-19 and sepsis.
Arch Virol. 2024;169:20. PubMedAbstract available
November 2023
JAMSHIDINIA N, Saadatpour F, Arefian E, Mohammadipanah F, et al Augmented antiviral activity of chlorhexidine gluconate on herpes simplex virus
type 1, H1N1 influenza A virus, and adenovirus in combination with salicylic
acid.
Arch Virol. 2023;168:302. PubMedAbstract available
ABDUL-KAREEM HH, Al-Maqtoofi MY, Burghal AA Impact of COVID-19 vaccination on saliva immune barriers: IgA, lysozyme, and
lactoferrin.
Arch Virol. 2023;168:293. PubMedAbstract available
WAN L, Li L, Zhang H, Liu C, et al The changing pattern of common respiratory viruses among children from 2018 to
2021 in Wuhan, China.
Arch Virol. 2023;168:291. PubMedAbstract available
October 2023
MOON SH, Na W, Shin S, Kim H, et al Evidence for the circulation of genotype 4 Eurasian avian-like lineage swine H1N1
influenza A viruses on Korean swine farms, obtained using a newly developed
one-step multiplex RT-qPCR assay.
Arch Virol. 2023;168:267. PubMedAbstract available
September 2023
MESEKO C, Ameji NO, Kumar B, Culhane M, et al Rational approach to vaccination against highly pathogenic avian influenza in
Nigeria: a scientific perspective and global best practice.
Arch Virol. 2023;168:263. PubMedAbstract available
DAVE B, Shah KC, Chorawala MR, Shah N, et al Molnupiravir: an antiviral drug against COVID-19.
Arch Virol. 2023;168:252. PubMedAbstract available
DEGIUSEPPE JI, Martelli A, Barrios Mathieur C, Stupka JA, et al Genetic diversity of rotavirus A in Argentina during 2019-2022: detection of G6
strains and insights regarding its dissemination.
Arch Virol. 2023;168:251. PubMedAbstract available
August 2023
TRIPATHY AS, Wagh P, Akolkar K, Walimbe AM, et al Association of inhibitory NKG2A and activating NKG2D natural killer cell receptor
genes with resistance to SARS-CoV-2 infection in a western Indian population.
Arch Virol. 2023;168:237. PubMedAbstract available
PHAM NTK, Khamrin P, Shimizu-Onda Y, Hoque SA, et al Genetic diversity and declining norovirus prevalence in infants and children
during Japan's COVID-19 pandemic: a three-year molecular surveillance.
Arch Virol. 2023;168:231. PubMedAbstract available
ZHOU Y, Chen Z Mpox: a review of laboratory detection techniques.
Arch Virol. 2023;168:221. PubMedAbstract available
July 2023
MA H, Ren S, Meng Q, Su B, et al Role of Tim-3 in COVID-19: a potential biomarker and therapeutic target.
Arch Virol. 2023;168:213. PubMedAbstract available
June 2023
FAYYAD-KAZAN M, Makki R, Homsi ME, Samadi A, et al Circulating microRNA profile in response to remdesivir treatment in coronavirus
disease 2019 (COVID-19) patients.
Arch Virol. 2023;168:194. PubMedAbstract available
LOBAINA Y, Chen R, Suzarte E, Ai P, et al Broad humoral immunity generated in mice by a formulation composed of two
antigens from the Delta variant of SARS-CoV-2.
Arch Virol. 2023;168:190. PubMedAbstract available
BHANOTHU V, Munne K, Pande S, Singh P, et al The dynamics of SARS-CoV-2 infection in unvaccinated and vaccinated populations
in Mumbai, India, between 28 December 2020 and 30 August 2021.
Arch Virol. 2023;168:188. PubMedAbstract available
SENTHILAZHAGAN K, Sakthimani S, Kallanja D, Venkataraman S, et al SARS-CoV-2: analysis of the effects of mutations in non-structural proteins.
Arch Virol. 2023;168:186. PubMedAbstract available
UPADHYAY R, Tiwari KN The antiviral potential of Phyllanthus species: a systematic review.
Arch Virol. 2023;168:177. PubMedAbstract available
VALDES-LOPEZ JF, Urcuqui-Inchima S Antiviral response and immunopathogenesis of interleukin 27 in COVID-19.
Arch Virol. 2023;168:178. PubMedAbstract available
PATTANAIK A, Bhandarkar B S, Lodha L, Marate S, et al SARS-CoV-2 and the nervous system: current perspectives.
Arch Virol. 2023;168:171. PubMedAbstract available
May 2023
ZHANG Y, Wang J, Xie Y, Cao X, et al Epidemiological characteristics of patients from fever clinics during the
COVID-19 epidemic in 2022 in Shanghai, China.
Arch Virol. 2023;168:164. PubMedAbstract available
SUHARSONO H, Mahardika BK, Sudipa PH, Sari TK, et al Consensus insertion/deletions and amino acid variations of all coding and
noncoding regions of the SARS-CoV-2 Omicron clades, including the XBB and BQ.1
lineages.
Arch Virol. 2023;168:156. PubMedAbstract available
TATSI EB, Koukou DM, Dellis C, Dourdouna MM, et al Epidemiological study of unusual rotavirus strains and molecular characterization
of emerging P[14] strains isolated from children with acute gastroenteritis
during a 15-year period.
Arch Virol. 2023;168:149. PubMedAbstract available
April 2023
MANSOURABADI AH, Aghamajidi A, Dorfaki M, Keshavarz F, et al B lymphocytes in COVID-19: a tale of harmony and discordance.
Arch Virol. 2023;168:148. PubMedAbstract available
DA COSTA MA, de Almeida RPA, Ponde RAA Clinical-laboratory profile of children and adolescents with multisystem
inflammatory syndrome temporarily associated with COVID-19 in Goias, Brazil.
Arch Virol. 2023;168:142. PubMedAbstract available
KAWABATA K, Sato Y, Kubo T, Tokumura A, et al Phospholipid analysis of two influenza A virus-infected cell lines differing in
their viral replication kinetics.
Arch Virol. 2023;168:132. PubMedAbstract available
March 2023
MARTINS M, do Nascimento GM, Conforti A, Noll JCG, et al A linear SARS-CoV-2 DNA vaccine candidate reduces virus shedding in ferrets.
Arch Virol. 2023;168:124. PubMedAbstract available
MAO L, Chen Y, Gu J, Zhao Y, et al Roles and mechanisms of exosomal microRNAs in viral infections.
Arch Virol. 2023;168:121. PubMedAbstract available
SHI T, Zhao X, Zhang X, Meng L, et al Immediate and long-term changes in the epidemiology, infection spectrum, and
clinical characteristics of viral and bacterial respiratory infections in Western
China after the COVID-19 outbreak: a modeling study.
Arch Virol. 2023;168:120. PubMedAbstract available
ZABIHI RIZI F, Ghorbani A, Zahtab P, Darbaghshahi NN, et al TYK2 single-nucleotide variants associated with the severity of COVID-19 disease.
Arch Virol. 2023;168:119. PubMedAbstract available
BORKAKOTI R, Karikalan M, Nehul SK, Jogi HR, et al A retrospective study showing a high rate of seropositivity against SARS-CoV-2 in
wild felines in India.
Arch Virol. 2023;168:109. PubMedAbstract available
February 2023
FALCON-CAMA V, Montero-Gonzalez T, Acosta-Medina EF, Guillen-Nieto G, et al Evidence of SARS-CoV-2 infection in postmortem lung, kidney, and liver samples,
revealing cellular targets involved in COVID-19 pathogenesis.
Arch Virol. 2023;168:96. PubMedAbstract available
SALEM S, Mosaad R, Lotfy R, Elbadry M, et al Altered expression of DNA methyltransferases and methylation status of the TLR4
and TNF-alpha promoters in COVID-19.
Arch Virol. 2023;168:95. PubMedAbstract available